Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients statewide.

Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients ...

Electroconvulsive therapy for depression is more effective and associated with fewer adverse effects in the patients aged 85 years or older than in younger patients, research shows.

Ambulatory clinical pharmacists improve patient outcomes and reduce health care costs by providing hands-on chronic disease management, patient education, and medication cost oversight, according ...

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable depression. The HHS and FDA voice support for psychedelics.

Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder Investor & Media Contact: Gabriel ...

On Friday, July 18, the Lynchburg Regional Business Alliance and Credence Behavioral Health officially cut the ribbon to their Wiggington Road location.

“Mental health is not just depression, schizophrenia, a mood disorder, anxiety; it has all of the things. We are trying to help patients where they are, rather than asking them to come to the ...

Kalamazoo TMS & Behavior Health provides state of the art therapies for out patients including treatment resistant depression including Transcranial Magnetic Stimulation (TMS), Nasal Esketamine ...